Drug Profile
Research programme: influenza therapeutic - onepharm
Alternative Names: OMP-3001Latest Information Update: 11 Nov 2009
Price :
$50
*
At a glance
- Originator onepharm
- Developer Minophagen; onepharm
- Class Carbohydrates; Triterpenes
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Influenza virus infections
Most Recent Events
- 11 Nov 2009 Discontinued for Influenza virus infections in Austria (unspecified route)